Evidence map›Paper›PMID 42306528›Full record

ReviewFrontiers in cellular and infection microbiology2026

Mapping the knowledge landscape of

Peng Zhao, Zejia Wang, Nan Jia, Xin Wang, Jingyu Liu, Yuanqi Zhu

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peng Zhao *Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zejia Wang *School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Nan Jia *Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xin WangGeneral Office, Zibo Mental Health Center, Zibo, China.
Jingyu LiuDepartment of Clinical Laboratory, Zibo Infectious Disease Hospital, Zibo, China.
Yuanqi ZhuDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: A bibliometric analysis was performed using publications retrieved from the Web of Science Core Collection and Scopus on December 20, 2025. The search covered the period 2014-2025 and focused on Results: Global research output on Conclusions: Research on

Indexed as

Anti-Bacterial AgentsBibliometricsBiofilmsDrug Resistance, Multiple, BacterialPseudomonas aeruginosaPseudomonas InfectionsClinical Trials as TopicHumansAnti-Bacterial Agentsanti-biofilm strategiesantimicrobial resistancebibliometric analysisbiofilm-mediated drug resistanceclinical trialsPseudomonas aeruginosa

Identifiers

PMID42306528
PMCPMC13265391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.